Search
CELL BANK Website

Back Back
RCB2640 : G-415  update : 2018/08/02
CommentHuman cell line derived from gallbladder carcinoma. TKG0642 (Deposited from Tohoku Univ.).
Comment from the depositor
Terms and conditionsBasically, there is no restriction regarding academic use.
Remarks
Order Form Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, Category I and II, depending on the sort of user institutions and the purposes of use.Please use an appropriate MTA(to see).In case of Restriction "a" or "f", please contact RIKEN BRC(cellbank.brc@riken.jp) regarding any kind of for-profit use.
Basic information Depositor Fukuda, Hiroshi
Originator Koyama, shohei
Year of deposit 2007
Original cell TKG0642
Animal human < Mammals
Genus Homo
Species sapiens
Gender Male
Age at sampling 68 years
Tissue gallbladder
Case history gallbladder carcinoma
Classification cancer
History Cell Resource Center for Biomedical Research, Tohoku University(TKG0642)
Lifespan infinite
Morphology epithelial-like
deposit info
lot info
Medium Medium List
Culture type Adherent cells
Medium and additives RPMI1640 + 10% FBS
Antibiotics Free
Passage method 0.25% trypsin
Culture information Passage ratio 1 : 8 split
SC frequency Subculture : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
STR(human) OK
Isozyme LD, NP
Images
deposit info
lot info
Reference information Reference 3
User's Publication 10


To topTop
Reference
5238  Koyama S.  Augmented human-tumor-cytolytic activity of peripheral blood lymphocytes and cells from a mixed lymphocyte/tumor culture activated by interleukin-12 plus interleukin-2, and the phenotypic characterization of the cells in patients with advanced carcinoma.  J Cancer Res Clin Oncol  1997  123(9):478-84.  PubMed ID: 9341896
5237  Koyama S, Mukai R, Fukao K, Arimura H, Iwasaki Y, Osuga T.  Monoclonal antibody against human gallbladder carcinoma-associated antigen.  Cancer Res  1987  47(17):4667-73  PubMed ID: 3304618
5236  Koyama S, Yoshioka T, Mizushima A, Kawakita I, Yamagata S, Fukutomi H, Sakita T, Kondo I, Kikuchi M.  Establishment of a cell line (G-415) from a human gallbladder carcinoma.  Gan  1980  71(4):574-5  PubMed ID: 7429092

To topTop
User's Publication
11395  Subbannayya T, Leal-Rojas P, Zhavoronkov A, Ozerov IV, Korzinkin M, Babu N, Radhakrishnan A, Chavan S, Raja R, Pinto SM, Patil AH, Barbhuiya MA, Kumar P, Guerrero-Preston R, Navani S, Tiwari PK, Kumar RV, Prasad TSK, Roa JC, Pandey A, Sidransky D, Gowda H, Izumchenko E, Chatterjee A.  PIM1 kinase promotes gallbladder cancer cell proliferation via inhibition of proline-rich Akt substrate of 40 kDa (PRAS40).  J Cell Commun Signal  2019    PubMed ID: 30666556
3726  Kirti Gondkar, Krishna Patel, Geeta V. Patil Okaly, Bipin Nair, Akhilesh Pandey, Harsha Gowda and Prashant Kumar  Dickkopf Homolog 3 (DKK3) Acts as a Potential Tumor Suppressor in Gallbladder Cancer  Front Oncol  2019  9:1121 
11742  Qin Y, Zhou Y, Ge A, Chang L, Shi H, Fu Y, Luo Q.  Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.  Biomed. Pharmacother.  2019    PubMed ID: 31401397
10170  Weber H, Valbuena JR, Barbhuiya MA, Stein S, Kunkel H, García P, Bizama C, Riquelme I, Espinoza JA, Kurtz SE, Tyner JW, Calderon JF, Corvalán AH, Grez M, Pandey A, Leal-Rojas P, Roa JC.  Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.  Oncotarget  2017  8:26169-26184  PubMed ID: 28412732
10222  Yang L, Huang S, Ma H, Wu X, Feng F.  MicroRNA-125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer.  Tumour Biol.  2017  39:1010428317692249  PubMed ID: 28347246
3727  Yeung Y, Lau DK, Chionh F, Tran H, Tse JWT, Weickhardt AJ, Nikfarjam M, Scott AM, Tebbutt NC, Mariadason JM  K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines.  Mol Oncol  2017  11(9):1130-1142  PubMed ID: 28544747
9533  Tadokoro T, Morishita A, Fujihara S, Iwama H, Niki T, Fujita K, Akashi E, Mimura S, Oura K, Sakamoto T, Nomura T, Tani J, Miyoshi H, Yoneyama H, Himoto T, Hirashima M, Masaki T.  Galectin-9: An anticancer molecule for gallbladder carcinoma.  Int. J. Oncol.  2016  48:1165-74  PubMed ID: 26797414
3735  Saha SK et al  Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma.  Cancer Discov  2016  6(7):727-39  PubMed ID: 27231123
7355  Saeki N, Ono H, Sakamoto H, Yoshida T.  Down-regulation of Immune-related Genes by PSCA in Gallbladder Cancer Cells Implanted into Mice.  Anticancer Res.  2015  35:2619-25  PubMed ID: 25964537
3729  Subbannayya T et al  Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.  BMC Cancer  2015  15:843  PubMed ID: 26530123



Back Back Return Top Page